ABSTRACT
Chronic kidney disease (CKD) is associated with excessive mortality from cardiovascular disease (CVD). Endothelial dysfunction, an early manifestation of CVD, is consistently observed in CKD patients and might be linked to structural defects of the microcirculation including microvascular rarefaction. However, patterns of microvascular rarefaction in CKD and their relation to functional deficits in perfusion and oxygen delivery are currently unknown. In this in-vivo microscopy study of the cremaster muscle microcirculation in BALB/c mice with moderate to severe uremia, we show in two experimental models (adenine feeding or subtotal nephrectomy), that serum urea levels associate incrementally with a distinct microangiopathy. Structural changes were characterized by a heterogeneous pattern of focal microvascular rarefaction with loss of coherent microvascular networks resulting in large avascular areas. Corresponding microvascular dysfunction was evident by significantly diminished blood flow velocity, vascular tone, and oxygen uptake. Microvascular rarefaction in the cremaster muscle paralleled rarefaction in the myocardium, which was accompanied by a decrease in transcription levels not only of the transcriptional regulator HIF-1α, but also of its target genes Angpt-2, TIE-1 and TIE-2, Flkt-1 and MMP-9, indicating an impaired hypoxia-driven angiogenesis. Thus, experimental uremia in mice associates with systemic microvascular disease with rarefaction, tissue hypoxia and dysfunctional angiogenesis.
Subject(s)
Hypoxia/etiology , Hypoxia/metabolism , Neovascularization, Pathologic/etiology , Neovascularization, Pathologic/metabolism , Renal Insufficiency, Chronic/complications , Vascular Diseases/etiology , Vascular Diseases/metabolism , Abdominal Muscles/blood supply , Animals , Biomarkers , Blood Flow Velocity , Blood Pressure , Coronary Vessels , Disease Models, Animal , Leukocyte Rolling/immunology , Male , Mice , Microcirculation , Microvascular Rarefaction , Myocardium , Neovascularization, Pathologic/physiopathology , Oxygen/metabolism , Renal Insufficiency, Chronic/diagnosis , Renal Insufficiency, Chronic/metabolism , Severity of Illness Index , Uremia/diagnosis , Uremia/etiology , Vascular Diseases/physiopathologyABSTRACT
AIM: Five photoactive compounds with variable elongated alkyl-substituents in a phenalen-1-one structure were examined in view of structural similarity to the antimicrobial agent benzalkonium chloride (BAC). METHODS: All phenalen-1-ones and BAC were evaluated for their antimicrobial properties against Staphylococcus aureus, methicillin-resistant S. aureus, Escherichia coli, Pseudomonas aeruginosa and for their eukaryotic toxicity against normal human epidermal keratinocyte (NHEK) cells to narrow down the BAC-like effect and the photodynamic effect depending on the chemical structure. All compounds were investigated for effective concentration ranges, where a bacterial reduction of 5 log10 is achieved, while an NHEK survival of 80% is ensured. RESULTS: Effective concentration ranges were found for four out of five photoactive compounds, but not for BAC and the compound with BAC-like alkyl chain length. CONCLUSION: Chain length size and polar area of the respective head-groups of phenalen-1-one compounds or BAC showed an influence on the incorporation inside lipid membranes and thus, head-groups may have an impact on the toxicity of antimicrobials.
Subject(s)
Anti-Bacterial Agents/pharmacology , Anti-Infective Agents, Local/pharmacology , Bacteria/drug effects , Benzalkonium Compounds/pharmacology , Phenalenes/pharmacology , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/radiation effects , Anti-Infective Agents, Local/chemistry , Anti-Infective Agents, Local/radiation effects , Benzalkonium Compounds/chemistry , Cell Line , Cell Membrane/chemistry , Escherichia coli/drug effects , Humans , Keratinocytes/drug effects , Light , Membrane Lipids/chemistry , Methicillin-Resistant Staphylococcus aureus/drug effects , Phenalenes/chemistry , Phenalenes/radiation effects , Pseudomonas aeruginosa/drug effects , Singlet Oxygen/chemistry , Staphylococcus aureus/drug effectsABSTRACT
Familial hypomagnesemia is a rare human disorder caused by renal or intestinal magnesium (Mg(2+)) wasting, which may lead to symptoms of Mg(2+) depletion such as tetany, seizures, and cardiac arrhythmias. Our knowledge of the physiology of Mg(2+) (re)absorption, particularly the luminal uptake of Mg(2+) along the nephron, has benefitted from positional cloning approaches in families with Mg(2+) reabsorption disorders; however, basolateral Mg(2+) transport and its regulation are still poorly understood. Here, by using a candidate screening approach, we identified CNNM2 as a gene involved in renal Mg(2+) handling in patients of two unrelated families with unexplained dominant hypomagnesemia. In the kidney, CNNM2 was predominantly found along the basolateral membrane of distal tubular segments involved in Mg(2+) reabsorption. The basolateral localization of endogenous and recombinant CNNM2 was confirmed in epithelial kidney cell lines. Electrophysiological analysis showed that CNNM2 mediated Mg(2+)-sensitive Na(+) currents that were significantly diminished in mutant protein and were blocked by increased extracellular Mg(2+) concentrations. Our data support the findings of a recent genome-wide association study showing the CNNM2 locus to be associated with serum Mg(2+) concentrations. The mutations found in CNNM2, its observed sensitivity to extracellular Mg(2+), and its basolateral localization signify a critical role for CNNM2 in epithelial Mg(2+) transport.
Subject(s)
Cation Transport Proteins/genetics , Cyclins/genetics , Genes, Dominant/genetics , Kidney/metabolism , Magnesium Deficiency/genetics , Magnesium/metabolism , Mutation/genetics , Amino Acid Sequence , Amino Acid Substitution/genetics , Animals , Base Sequence , Cation Transport Proteins/chemistry , Cyclins/chemistry , Electrophysiological Phenomena/drug effects , Female , HEK293 Cells , Humans , Immunohistochemistry , Kidney/drug effects , Kidney/pathology , Magnesium/pharmacology , Magnesium Deficiency/pathology , Male , Mice , Molecular Sequence Data , Nephrons/drug effects , Nephrons/metabolism , Nephrons/pathology , Pedigree , Up-Regulation/drug effectsABSTRACT
Claudin-16 (CLDN16) is critical for renal paracellular epithelial transport of Ca(2+) and Mg(2+) in the thick ascending loop of Henle. To gain novel insights into the role of CLDN16 in renal Ca(2+) and Mg(2+) homeostasis and the pathological mechanisms underlying a human disease associated with CLDN16 dysfunction [familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC), OMIM 248250], we generated a mouse model of CLDN16 deficiency. Similar to patients, CLDN16-deficient mice displayed hypercalciuria and hypomagnesemia. Contrary to FHHNC patients, nephrocalcinosis was absent in our model, indicating the existence of compensatory pathways in ion handling in this model. In line with the renal loss of Ca(2+), compensatory mechanisms like parathyroid hormone and 1,25(OH)(2)D(3) were significantly elevated. Also, gene expression profiling revealed transcriptional upregulation of several Ca(2+) and Mg(2+) transport systems including Trpv5, Trpm6, and calbindin-D9k. Induced gene expression was also seen for the transcripts of two putative Mg(2+) transport proteins, Cnnm2 and Atp13a4. Moreover, urinary pH was significantly lower when compared with wild-type mice. Taken together, our findings demonstrate that loss of CLDN16 activity leads to specific alterations in Ca(2+) and Mg(2+) homeostasis and that CLDN16-deficient mice represent a useful model to further elucidate pathways involved in renal Ca(2+) and Mg(2+) handling.
Subject(s)
Calcium/metabolism , Claudins/deficiency , Claudins/genetics , Gene Deletion , Hypercalciuria/metabolism , Magnesium/metabolism , Nephrocalcinosis/metabolism , Renal Tubular Transport, Inborn Errors/metabolism , Adenosine Triphosphatases/metabolism , Animals , Biological Transport/physiology , Cation Transport Proteins/metabolism , Claudins/metabolism , Disease Models, Animal , Homeostasis/physiology , Hypercalciuria/physiopathology , Membrane Transport Proteins , Mice , Mice, Knockout , Nephrocalcinosis/physiopathology , Renal Tubular Transport, Inborn Errors/physiopathology , Signal Transduction/physiologyABSTRACT
BACKGROUND: Occlusive vascular changes, characterized by the formation of a neointima with lumen obstruction, are key histologic findings of allograft arteriosclerosis. Vascular integrity of the graft is critically dependent on nitric oxide (NO), synthesized by NO synthases (NOS), of which three isoforms have been located in the arterial wall: endothelial NOS (eNOS), inducible NOS, and neuronal NOS (nNOS). We have studied the role of NOS in a murine model of aortic allograft rejection. METHODS: The descending thoracic aorta of donor mice (BALB/c mice) was transplanted into two groups of recipients: (a) C57BL/6J and (b) C57BL/6J mice homozygous (-/-) for a knockout of the eNOS gene (eNOS(-/-)). RESULTS: After 4 weeks, pronounced neointima formation, upregulated expression of adhesion molecules, and increased infiltration by inflammatory cells were demonstrated in wild-type recipient mice, whereas eNOS(-/-) recipient mice were protected from neointima development by a significantly increased synthesis of NO, as shown by increased formation of cGMP; this was mainly explained by upregulation of inducible NOS and nNOS. CONCLUSIONS: Upregulation of inducible NOS and nNOS isoforms may be beneficial in preventing allograft arteriosclerosis in the early posttransplant period.
Subject(s)
Aorta, Thoracic/transplantation , Arteriosclerosis/prevention & control , Nitric Oxide Synthase Type III/deficiency , Animals , Cell Adhesion , Cell Division , Cyclic GMP/metabolism , DNA Primers , Homozygote , Kidney/enzymology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout/genetics , Myocardium/enzymology , Nitric Oxide/metabolism , Nitric Oxide Synthase Type I/genetics , Nitric Oxide Synthase Type III/genetics , Postoperative Complications/prevention & control , RNA/genetics , RNA/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction , Tunica Intima/pathologyABSTRACT
In the kidney, approximately 80% of the filtered phosphate (Pi) is reabsorbed along the proximal tubule. Changes in renal Pi reabsorption are associated with modulation of the sodium-dependent Pi cotransporter type IIa (NaPi-IIa) and type IIc (NaPi-IIc) protein abundance in the brush-border membrane (BBM) of proximal tubule cells. NaPi-IIa is mainly regulated by dietary Pi intake and parathyroid hormone (PTH). The purpose of the present study was to elucidate the effect of alteration in dietary magnesium (Mg2+) intake on renal Pi handling. Urinary Pi excretion and renal expression of NaPi-IIa and NaPi-IIc were analyzed in rats fed a normal (0.2%) or high-Mg2+ (2.5%) diet. A high-Mg2+ diet resulted in decreased renal Pi excretion and increased protein expression of NaPi-IIa and NaPi-IIc. Serum FGF-23 (fibroblast growth factor 23) levels were unchanged under a high-Mg2+ diet. Serum PTH levels were slightly decreased under a high-Mg2+ diet. To examine whether the observed changes in renal Pi reabsorption are PTH dependent, expression of NaPi-IIa and NaPi-IIc was also analyzed in parathyroidectomized (PTX) rats fed a normal or high-Mg2+ diet. In PTX rats, Mg2+ had no significant effect on renal Pi excretion or NaPi-IIa protein expression. Mg2+ increased NaPi-IIc protein expression in PTX rats. This experiment shows for the first time on the molecular level how Mg2+ stimulates renal Pi reabsorption. Under a high-Mg2+ diet, NaPi-IIa expression is dependent on PTH levels, whereas NaPi-IIc expression seems to be independent of PTH levels.